[go: up one dir, main page]

GB202310868D0 - compositions and methods of use - Google Patents

compositions and methods of use

Info

Publication number
GB202310868D0
GB202310868D0 GBGB2310868.1A GB202310868A GB202310868D0 GB 202310868 D0 GB202310868 D0 GB 202310868D0 GB 202310868 A GB202310868 A GB 202310868A GB 202310868 D0 GB202310868 D0 GB 202310868D0
Authority
GB
United Kingdom
Prior art keywords
compositions
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2310868.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Blueberry Therapeutics Ltd
Original Assignee
Blueberry Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Blueberry Therapeutics Ltd filed Critical Blueberry Therapeutics Ltd
Priority to GBGB2310868.1A priority Critical patent/GB202310868D0/en
Publication of GB202310868D0 publication Critical patent/GB202310868D0/en
Ceased legal-status Critical Current

Links

GBGB2310868.1A 2023-07-14 2023-07-14 compositions and methods of use Ceased GB202310868D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GBGB2310868.1A GB202310868D0 (en) 2023-07-14 2023-07-14 compositions and methods of use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2310868.1A GB202310868D0 (en) 2023-07-14 2023-07-14 compositions and methods of use

Publications (1)

Publication Number Publication Date
GB202310868D0 true GB202310868D0 (en) 2023-08-30

Family

ID=87758539

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2310868.1A Ceased GB202310868D0 (en) 2023-07-14 2023-07-14 compositions and methods of use

Country Status (1)

Country Link
GB (1) GB202310868D0 (en)

Similar Documents

Publication Publication Date Title
IL309073A (en) Enantiomeric entactogen compositions and methods of their use
SI4267105T1 (en) Antibody compositions and methods of use thereof
IL314320A (en) Compounds and methods of use
IL308041A (en) Collagen compositions and methods of use thereof
EP4121224A4 (en) Cleaning compositions and methods of use thereof
GB202319843D0 (en) CAS13-based compositions and methods of use thereof
IL312928A (en) Complement factor b-modulating compositions and methods of use thereof
EP4204004A4 (en) Anti-idiotype compositions and methods of use thereof
EP4381022A4 (en) Compositions and methods of use thereof
IL318328A (en) Compositions including multi-agonist peptides and methods of manufacture and use
EP4298076A4 (en) Ceramic compositions and methods of use
IL314226A (en) Designed cytokine compositions and methods of use
IL318393A (en) Aza-quinazoline compounds and methods of use
IL314277A (en) Anti-b7-h3 compounds and methods of use
IL315862A (en) Angiotensinogen-modulating compositions and methods of use thereof
IL316049A (en) Pharmaceutical compositions of mosunetuzumab and methods of use
GB202313643D0 (en) Serping1-sarna compositions and methods of use
GB202310868D0 (en) compositions and methods of use
IL324171A (en) Mivelsiran compositions and methods of use thereof
IL323920A (en) Mapt-modulating compositions and methods of use thereof
IL312205A (en) Coxsackievirus b compositions and methods of use thereof
IL321134A (en) Olanzapine compositions and methods of use
HK40115145A (en) Angiotensinogen-modulating compositions and methods of use thereof
HK40115640A (en) Prekallikrein-modulating compositions and methods of use thereof
HK40114450A (en) Angiotensinogen-modulating compositions and methods of use thereof

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)